Table 4.
Strategy | False positives, % | False negatives, % | ||||
Mean | (95% CI) | p Value | Mean | (95% CI) | p Value | |
(1) Standard | 6.6 | (6.4 to 6.9) | 3.4 | (3.2 to 3.6) | ||
(2) hsTnI | 7.0 | (6.7 to 7.2) | 0.06* | 3.0 | (2.8 to 3.2) | 0.002* |
(3) hsTnI+LoD | 6.5 | (6.3 to 6.8) | 0.62*; 0.02† | 3.0 | (2.8 to 3.2) | 0.002*; 1.00† |
(4) hsTnI+ ADP | 3.4 | (3.2 to 3.5) | <0.001*,† | 3.0 | (2.9 to 3.2) | 0.005*; 0.84† |
(5) hsTnI+LoD+ADP | 3.3 | (3.1 to 3.4) | <0.001*,† | 3.0 | (2.9 to 3.2) | 0.005*; 0.84† |
(6) hsTnI+LoD+ADP+direct rule-in | 3.3 | (3.1 to 3.4) | <0.001*,† | 2.8 | (2.6 to 2.9) | <0.001*; 0.05† |
False positives: Number of patients diagnosed with ACS and a 30 days adjudicated diagnosis of non-ACS.
False negatives: Number of patients not diagnosed with ACS and a 30 days adjudicated diagnosis of ACS.
*p Value versus strategy 1 (standard care)
†p Value versus strategy 2 (hsTnI)
ACS, acute coronary syndrome; ADP, modified ADAPT accelerated diagnostic protocol; hsTnI, high-sensitivity troponin I; LoD, limit of detection.